Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-01-30-Speech-4-053"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20030130.2.4-053"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
". – Mr President, Commissioners do talk to each other and sometimes even write to each other. I maintain that what we have achieved in this field of communicable diseases represents a good illustration of the Commission working across the different areas of responsibility. This initiative would never have been launched and achieved its results without that work attitude. As to the issue of further research into these diseases, this is also reflected in what my colleague Mr Busquin is doing, and the Sixth Framework Programme for European Research places greater emphasis on this research in order to accelerate it. I agree that the pharmaceutical companies are not doing enough in this area from the point of view of global poverty. It is interesting to note that the Melinda and Bill Gates Foundation has recently announced the availability of 200 million US dollars by way of a competition fund to prompt pharmaceutical companies to attract that money for accelerated research into malaria, TB and AIDS, but mainly malaria. We will work with them and are of course already in contact with them, as this makes sense. I would once again point out that when, as in this instance, Parliament is trying to raise additional funds for these activities, this is of course a welcome development.
As a Commissioner, I have to tell you that the Commission does not print money. We have to work within the constraints of the budget and the perspective as defined by the budgetary authority as a whole. So I repeat: we cannot accept the amendment regarding the EUR 351 million."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples